View Older Stories View More Recent Stories
-
Top 10 News Items for 6/28-7/2: Nonfarm Payrolls Beat, Unemployment Rate Comes in at 9.5%; Tesla's IPO En Fuego; House Passes FinReg Bill
-
Notable Analyst Rating Changes 06/07: BMY, EGLE, CELG, NILE Upgraded; BP, TEL, SPWRA, ABT Downgraded
-
Citi Announces Highlights from Recent Healthcare Conference
-
Wall Street Giddy About Dendreon (DNDN) After Provenge Approval; Where Are Shares Headed?
-
Notable Analyst Rating Changes 04/29: PALM, AKAM, FSLR, AFL Upgraded; AKS, VNDA, CMA Downgraded
-
Citi Maintains a 'Buy' on Celgene (CELG); HC Reform Impact Small
-
Citi Maintains a 'Buy' on Biotechnology and Drugs Stocks CELG & MJN - Raises PTs
-
Trading Radar for 01/28: Amazon.com (AMZN), Microsoft (MSFT), Chubb (CB), AT&T (T), Ford Motor (F), L-3 (LLL) Report
-
Notable Analyst Rating Changes 9/21: WFC, NTAP, MAR, SHO, COST, CELG Upgraded; BK, POT, MOS, AMSC, MO Downgraded
-
Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded
-
Notable Analyst Rating Changes 8/6: AXP, MGM, OWW, FCX, SPLS, DD Upgraded; CELG, FITB, OCNF, MELI, SHO Downgraded
-
Morning Movers 7/23: MEDX, ISRG, SANM, AFFX, MNI, CCMP, SPF Higher; FREE, CRA, CTIC, MCO, CIT, PSUN, TEX Lower
-
Notable Analyst Rating Changes 7/22: SBUX, KFT, CSCO, STX Upgraded; FCX, AAN, NOC, BTU Downgraded
-
Barclays Gets Bullish On US Biotechnology Sector (BBH)
-
Notable Analyst Rating Changes 5/8: BAC, TGT, AXL, IR Upgraded; BBY, MRO, SONC, CELG Downgraded
-
David Moenning's Daily State of the Markets: 5/8
-
David Moenning's Daily State of the Markets: 4/30
-
Unusual 11 Mid-Day Movers 4/1: ZZ, ONTY, FCFC, LCUT Higher; TKP, SAH, GFG, APOL Lower
-
Citi Maintains a 'Buy' on Celgene (CELG); Removed From Top Picks Live List
-
Morning Movers 4/1: ZZ, SOA, MV, PDO, HYTM Higher; SGIC, SAH, TGEN, TISI, ZOLL, CELG Lower
-
Celgene (CELG) to Present at 4th Annual Citi Biotech Day; Sees FY09 Sales, EPS at Low End of Range
-
After-Hours Movers 3/31: LVS, BGP, HYTM, ZZ Higher; ZOLL, HLYS, BW, CELG, TISI, OSK Lower
-
Notable Analyst Rating Changes 2/18: S, SNN, NYX, CPRT Upgraded; ENTG, HOS, GPC, AMX Downgraded
-
David Moenning's Daily State of the Markets: 1/29
-
Citi Maintains a 'Buy' on Celgene Corp (CELG), Attractive Buying Opportunity
-
Citi Maintains 'Buy' on Celgene Corp (CELG), Sell-Off Overdone
-
David Moenning's Daily State of the Markets:
-
Citi Introduces Investment Research's TEN+ (Ten Exceptional Names Plus) List for 2008-09
-
David Moenning's Daily State of the Markets: 5/8
-
Notable Analyst Rating Changes 5/9: ATVI, NVDA, HES Upgraded; CELG, PEC, DRS Downgraded

